PX’THERAPEUTICS and ADVAXIS to collaborate for the process development of Lm based immunotherapies

,
Grenoble (France), January 17th, 2018 - PX’Therapeutics, a CDMO (Contract Development and Manufacturing Organization) has signed an agreement with Advaxis, Inc., a US-based, clinical stage biotechnology company, to support it in the process


Toleranzia AB signs agreement with PX’Therapeutics for large scale manufacturing of TOL2

,
Press release 2017-12-20 - Toleranzia AB ("Toleranzia") hereby announces that the company has entered into an agreement with the French contract manufacturer PX'Therapeutics SAS ("PX'") for large scale production of the drug candidate TOL2. The


Detecting sleep apnea: LETI embeds sensors in wristband to measure heart rate and three other indicators

,
APNEAband, Which Will Be Demonstrated at CES 2018, Also Monitors Mountain Sickness, Dehydration, Dialysis Treatment Response and Epileptic Seizures GRENOBLE, France – Dec. 12, 2017 – Leti, a research institute of CEA Tech, will demonstrate


PX’THERAPEUTICS announces the successful completion of RGP41 GMP manufacturing for Mymetics

,
Grenoble, France, and Epalinges, Switzerland, December 12th, 2017  - PX’Therapeutics, a CDMO specializing in the development of recombinant proteins for human and animal health, is proud to announce the end of the rgp41 manufacturing campaign


TECHNIDATA participates in the microbiology lab modernization of the Grenoble Alpes University Hospital: a laboratory at the forefront of technology thanks to lab automation and paperless microbiology.

,
Montbonnot (France), December 7, 2017 - The Grenoble Alpes University Hospital (CHUGA) leverages innovation and performance to build its development strategy. In this context, the hospital microbiology laboratory has decided to automate its


LETI develops MEG technology to improve diagnosis of epilepsy and guide surgeons during brain surgery

,
‘Disruptive’ Magnetoencephalography System that also Lowers Costs and Enhances Scan Accuracy Wins Best Early Stage Innovation Award from European Commission GRENOBLE, France – Nov. 30, 2017 – Leti, a research institute of CEA Tech,


3.2 M€ INOVOLINE (FUI-24) project approved for automated in vivo testing of new anticancer drugs!

,
INOVOTION has been awarded an ambitious project for automating its revolutionary Drug Discovery in vivo efficacy and toxicity testing technology. The underlying technology is already a game changer for developing new anticancer drugs: in vivo


ALPAO extends its range of deformable mirrors and adaptive optics systems

,
Grenoble (France) – November 8, 2017 – The French company ALPAO marks a milestone to complete range of adaptive optics products. The company reviewed its deformable mirrors, wavefront sensors and adaptive optics systems to fit all applications


Compamed 2017: RAUMEDIC presents itself as a single-source provider

When Compamed opens its doors from November 13 to 16 in DĂŒsseldorf, medical device manufacturer RAUMEDIC will again be there. With the trade fair motto, “All from one source”, the company will present the trade audience its polymer solutions


IMACTIS to accelerate the development of its “GPS” dedicated to interventional radiology with €3m series B led by M Capital Partners

Grenoble – October 23rd, 2017 – IMACTIS is a medical technologies company founded by Lionel Carrat and StĂ©phane LavallĂ©e. The company focuses on the development of innovative computer assisted solutions for interventional radiology. After